Cidara Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cidara Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q3 2024.
  • Cidara Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$17.4M, a 289% decline year-over-year.
  • Cidara Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$140M, a 539% decline year-over-year.
  • Cidara Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$24.5M, a 26.9% increase from 2022.
  • Cidara Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$33.5M, a 20.7% increase from 2021.
  • Cidara Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$42.3M, a 41.2% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$140M -$17.4M -$12.9M -289% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$127M -$96M -$89.2M -1322% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$38M -$10.7M -$13.5M -484% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$24.5M -$16M -$2.56M -19% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-22
Q3 2023 -$21.9M -$4.47M -$18.7M -131% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$3.26M -$6.75M +$9.01M +57.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$12.3M $2.78M +$21.2M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$33.5M -$13.5M +$3.28M +19.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-22
Q3 2022 -$36.8M $14.2M +$32.2M Jul 1, 2022 Sep 30, 2022 10-K 2024-04-22
Q2 2022 -$69M -$15.8M -$26.5M -246% Apr 1, 2022 Jun 30, 2022 10-K 2024-04-22
Q1 2022 -$42.5M -$18.5M -$232K -1.27% Jan 1, 2022 Mar 31, 2022 10-K 2024-04-22
Q4 2021 -$42.3M -$16.8M +$4.78M +22.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$47M -$18M -$507K -2.89% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$46.5M $10.8M +$29M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$75.5M -$18.2M -$3.66M -25.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$71.8M -$21.5M -$7.47M -53% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 -$64.4M -$17.5M -$20.6M -679% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$43.8M -$18.2M -$3.94M -27.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$39.9M -$14.6M +$1.84M +11.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$41.7M -$14.1M +$2.52M +15.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-07
Q3 2019 -$44.2M $3.03M +$17.8M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$62M -$14.3M +$884K +5.83% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$62.9M -$16.4M +$406K +2.42% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$63.3M -$16.6M -$3.14M -23.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$60.1M -$14.7M -$2.48M -20.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$57.7M -$15.2M +$1.46M +8.81% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$59.1M -$16.8M -$3.41M -25.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$55.7M -$13.5M +$894K +6.23% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-04
Q3 2017 -$56.6M -$12.2M +$87K +0.71% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$56.7M -$16.6M -$4.75M -40.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$51.9M -$13.4M -$3.51M -35.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$48.4M -$14.4M -$4.43M -44.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$44M -$12.3M -$3.13M -34% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$40.9M -$11.9M -$5.42M -84% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$35.5M -$9.89M -$3.15M -46.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$32.3M -$9.93M -$5.28M -114% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$27M -$9.21M -$5.89M -177% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$21.1M -$6.45M -$3.35M -108% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$17.8M -$6.73M -$6.17M -1104% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$11.6M -$4.65M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$3.32M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$3.1M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$559K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.